PubMed:32712670 / 0-252
Annnotations
LitCovid-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 29-38 | CHEBI:31781 | denotes | lopinavir |
| T2 | 29-38 | DG_23 | denotes | lopinavir |
| T3 | 29-38 | CHEBI:31781 | denotes | lopinavir |
| T4 | 48-57 | DG_13 | denotes | darunavir |
| T5 | 67-82 | UBERON:0002450 | denotes | decidualization |
| T6 | 122-127 | GO:0007567 | denotes | birth |
| T7 | 153-164 | GO:0007565 | denotes | pregnancies |
| T8 | 233-247 | CHEBI:35705 | denotes | antiretroviral |
| T9 | 233-247 | CHEBI:35705 | denotes | antiretroviral |
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-165 | Sentence | denotes | Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies. |
| T2 | 166-181 | Sentence | denotes | STUDY QUESTION: |
| T1 | 0-165 | Sentence | denotes | Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies. |
| T2 | 166-181 | Sentence | denotes | STUDY QUESTION: |